Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

ALXOALXO
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in ALX ONCOLOGY HLDGS INC

JPMORGAN CHASE & CO holds 1M shares of ALXO (ALX ONCOLOGY HLDGS INC), worth $2.3M as of 2026-Q2. The position was increased (+10.6Kx shares). ALXO represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$2.3M

Current Shares

1M

Total Value Change

+$1.9M

Total Shares Change

+808,682

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+10.6Kx
$2.3M0.0%$2.07
42
2026-Q1
Unchanged
99
0.0%
$1890.0%$2.07
0
2025-Q4
Decreased
99
-99.9%
$1120.0%$1.19
0
2025-Q3
Increased
123,798
+40.1%
$226,5500.0%$1.75
21
2025-Q2
Decreased
88,352
-75.3%
$36,6750.0%$0.41
0
2025-Q1
Increased
357,957
+51.6%
$223,0070.0%$0.65
22
2024-Q4
New
236,046
-
$394,1970.0%$1.66
36

Other major holders of ALXO: Janus Henderson Group Ltd., Invesco Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used